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http://dxObjectives: The singularity of the ascending aorta regarding mechanisms driving aneurysm formation requires
the development of specific animal models. We investigated if adventitial elastase application results in ascend-
ing aorta aneurysms in rats.
Methods: Adult Lewis rats (n ¼ 26) were anesthetized, their ascending aortas measured by transthoracic
ultrasound, and exposed via median sternotomy. Elastase or saline was applied on the ascending aortic adven-
titia. Ascending aorta diameters were monitored by ultrasound at 10 and 30 days, when the animals were killed.
Wall area was measured on orcein stained sections. Matrix metalloproteinase-2 and matrix metalloproteinase-9
levels were quantified on gelatin zymography.
Results: Following elastase application, ascending aortic diameter increased at 10 and 30 days follow-up by
38% and 44%, respectively (P¼ .004). Despite thinning of the media secondary to vascular dilation, standard-
ized medial area was not different between elastase-treated aortas and controls. Standardized total wall area had
a significant increase in treated aortas compared with controls. Active matrix metalloproteinase-2 was signifi-
cantly increased at 30 days in treated aortas, whereas active matrix metalloproteinase-9 was no different from
controls.
Conclusions: Elastase application on rat ascending aortic adventitia produced aneurysms, creating a reproduc-
ible model. Aortic wall remodeling evolved toward an increase in total wall area, reproducing the main structural
features of this disease in human beings. (J Thorac Cardiovasc Surg 2013;145:1627-34)Sixty percent of thoracic aortic aneurysms involve the as-
cending aorta and predispose patients to life-threatening
complications, including aortic dissection and rupture.1
Most of these ascending thoracic aortic aneurysms
(ATAAs) are degenerative; that is, independent of an overt
connective-tissue disorder or a definite genetic background.
Although the incidence and prevalence of thoracic aortic
aneurysms are increasing,2 the mechanisms by which
ATAAs develop in individuals with no identified genetic
syndrome remain poorly understood. Recent research on ar-
terial aneurysms has benefited from the development of an-
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research on innovative treatment options.3-6 There is no
reproducible model for degenerative ATAAs located in
a segment of the aorta with particular characteristics likely
to determine mechanisms of formation and particular
therapeutic approaches. Besides specific anatomic, his-
tologic, mechanical, and hemodynamic characteristics,7
the ascending aorta originates from an embryonic structure
distinct from the origin of other segments of the aorta.
Vascular smooth muscle cells (VSMCs) of the abdominal
aorta have mesenchymal origin, whereas VSMCs of the
ascending aorta originate in the cardiac neural crest exhibit-
ing lineage-dependant responses to growth factors.8,9 As an
illustration of these specificities, risk factors and pathologic
features of ATAAs differ from those of aneurysms in other
locations along the aorta.10 These specificities prompted
us to develop an animal model ATAA.
The goal of our study was to test the hypothesis that elas-
tase application onto the ascending aorta in rats would
produce aneurysms sharing common features of human
ATAAs.MATERIALS AND METHODS
Animals
Twenty-six adult, male, in-bred 16-week old Lewis rats (mean weight
445 g) (Janvier, Le Genest-St-Isle, France) were randomly assigned fordiovascular Surgery c Volume 145, Number 6 1627
Abbreviations and Acronyms
a-SMA ¼ alpha smooth muscle actin
ATAA ¼ ascending thoracic aortic aneurysm
MMP ¼ matrix metalloproteinase
VSMC ¼ vascular smooth muscle cell
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Streatment and followed for 30 days. The animals were weighed, anesthe-
tized by intraperitoneal injection of 5.5 mg/100 g body weight pentobarbi-
tal (Ceva Sante Animale, Libourne, France), and shaved. Animals were
treated and cared for in accordance with The European Convention for
the protection of vertebrate animals used for experimental and other scien-
tific purposes of the European Council.
Aneurysm Model
The animals were anesthetized and an anterior midline incision was
made from the neck to the xyphoid process. Rats were subjected to retro-
grade intubation and ventilated with room air using a Harvard Rodent Ven-
tilator 683 (Harvard Apparatus, Holliston, Mass), set at a respiratory rate of
55 to 65 breaths per minute, with a tidal volume of 2 mL. A median ster-
notomy was performed and the thymus was retracted toward the neck to
expose the ascending aorta.
The ascending aorta was dissected free from the pulmonary artery and
100 mL elastase solution (160 U/mL) (porcine pancreas elastase, Serva
Electrophoresis, Heidelberg, Germany) or physiologic saline (Fresenius
Kabi, Sevres, France) was applied on a swab that was wrapped around
the aorta during 40 minutes. At the end of treatment the thoracic wall
was closed in 2 layers with separate stitches of 4-0 polypropylene (Prolene;
Ethicon, Johnson and Johnson Co, Cornelia, Ga). Pneumothorax was re-
duced by obstructing outflow on the ventilator for 4 to 5 breaths just before
tight closure of the chest. The respiratory rate was gradually decreased and
the rat was extubated when it showed evidence of good spontaneous respi-
ration. During follow-up, animals were monitored daily and given water
and chow ad libitum.
Ultrasound Imaging
The noninvasive method for measuring diameter of the ascending aorta
in rats by ultrasound has been described elsewhere.11 Aortic imaging was
performed in anesthetized animals in dorsal recumbence, using
a VINGMEDCFM750 scanner with a transducer at an operating frequency
of 9MHz (GE, Fairfield, Conn). The transducer was placed on the left hemi
thorax and oriented to provide a longitudinal image of the ascending aorta
in parasternal incidence. Localization of the vessels was determined by
pulse Doppler signal. Ascending aortic diameters were measured in late
systole, strictly marking the inner aortic diameter at midpoint between
the sinotubular junction and the origin of the brachiocephalic trunk. The
mean of 3 separate measurements was retained. Ultrasound measurements
were performed under the same conditions before surgical intervention, at
10 and 30 days of follow-up, by the same observer, blinded with respect to
the animal’s experiment group. Arterial blood pressure was not monitored.
Tissue Harvesting and Histology
Before euthanasia, ultrasound measurements were repeated under gen-
eral anesthesia. First animals killed from the elastase-treated and control
groups underwent angiography by direct exposure of the right carotid artery
and injection of 3 mL contrast agent through a catheter (Insyte Auto-
guard22GA, 25mm, BD, Franklin Lakes, NJ). After orotracheal intubation
the thorax was opened under the xiphoid process and the anterior chest wall
was removed. An incision was made in the right atrium to provide an outlet
for blood and perfusate. The left ventricle was then punctured with a 21-G
needle inserted in the direction of the left ventricular outflow tract. The1628 The Journal of Thoracic and Cardiovascular Surneedle was attached to a perfusion system that provided initial perfusion
with normal saline at 100 mmHg. The saline perfusion was continued until
outflow from the right atrium incision was clear and the liver appeared ex-
sanguinated. The animal was then perfused with 70% ethanol for 3minutes
and the ascending aorta was harvested from the annulus to the origin of the
brachiocephalic trunk. The harvested tissue was fixed in 70% ethanol for
24 hours at 4C and embedded in paraffin. Cross-sections 6-mm thick
were stained with orcein and Sirius red for elastin and collagen fibers, re-
spectively. A monoclonal mouse antibody against alpha smooth muscle ac-
tin (a-SMA) (1A4 clone; DakoCytomation, Carpinteria Calif) was used and
revealed by immunoperoxidase using a Vectastain Elite ABC kit (PK-6102;
Vector Laboratory, Burlingame, Calif). Negative controls were generated
by omission of the primary antibody, and a nonrelevant antibody.
Quantifications of internal vessel perimeter, medial thickness, medial
area, and total wall area were realized on orcein stained aortas using Axi-
oCamICc1 camera mounted on AxioImager D1 microscope with AxioVi-
sion software (Zeiss, Germany). For medial thickness a mean from four
measurements taken at 3, 6, 9, and 12 o’clock was retained.
Quantification of Gelatinase Activities
After pulverization of the aortic tissue using a MultiSample Biopulver-
izer (BioSpec Products, VWR International, France), extracts were pre-
pared with ice-cold 0.2% Triton X-100 in 0.05 mol/L Tris-HCl, pH 7.6
containing 0.01 mol/L calcium chloride. Protein content was determined
by bicinchoninic acid assay quantification according to the manufacturer’s
recommendations. Fifteen microgram extracts per lane were subjected to
a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis contain-
ing 0.1% gelatin. After electrophoresis, gels were washed in 2.5% Triton
X-100 for 30 minutes, further incubated for 24 hours at room temperature
in 50 mmol/L Tris, pH 8.2 containing10 mmol/L calcium chloride, and
finally stained with 0.008% Coomassie brilliant blue (Sigma Chemical
Co, St Louis, Mo). Quantitative analysis of matrix metalloproteinase
(MMP) activity was performed using QuantityOne software (4.6.3, 2006;
Bio-Rad, Hercules, Calif).
Experimental Design
Animals were randomly assigned to treatment groups before anesthesia.
Fifteen rats received elastase and 6 received physiologic saline (control
group). Rats were put to death at day 10 (5 elastase-treated and 3 control-
group rats) and day 30 (10 elastase-treated and 3 control-group rats).
Statistical Analysis
Results are expressed as medians and range. Nonparametric tests were
used for comparisons between groups: Mann-Whitney U test or Wilcoxon
matched pairs test for comparison of 2 groups and Kruskal-Wallis test for
comparison of 3 or more groups. All tests were performed using GraphPad
Prism version 4 (2003; GraphPad Software, San Diego, Calif).RESULTS
Operative Observations
Mortality was 19% (5 rats). Elastase application on the
ascending aortic adventitia resulted in immediate and repro-
ducible ascending aortic dilation (Figure 1). The dilation
progressed during exposure to elastase. An aortic rupture
occurred at the end of elastase application in 3 animals.
One treated and 1 control animal died during follow-up,
at day 2 and 3, respectively. The dilation was limited at
the tubular portion of the ascending aorta without involve-
ment of the aortic root. No aortic dilation was observed in
control animals. Angiography performed before sacrificegery c June 2013
FIGURE 1. A, Intraoperative view through the operating microscope showing the entire ascending aorta with the beginning of the brachiocephalic trunk
and aortic arch at the top, before elastase treatment. B, Ascending aorta after elastase treatment. C, Angiography performed at 30-day follow-up, before
death, showing thoracic aorta in a control group animal and (D), a treated animal.
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lar portion of the ascending aorta in elastase-treated rats
(Figure 1).
Aortic Diameters and Wall Thickness
Iterative measurements by transthoracic ultrasound re-
vealed a progressive and significant increase of the ascend-
ing aorta diameter in elastase-treated animals compared
with saline-treated control animals. At 10- and 30-day
follow-up median aortic diameter had an increase of 38%
and 44%, respectively, compared with the preoperative
value (P<.05 for both) (See Figure 2 and Table 1).
Themedial layer of the treated aortas showed a significant
thinning compared with medial thickness of control aortas
(21% and 26% decrease in medial thickness at 10- and
30-day follow-up, respectively; P<.05) (Figure 2, B, and
Table 1). However, the vascular wall layers are predicted
to thin in response to vascular dilation alone (in the absence
of any atrophic vessel wall changes); for example, in an aorta
that increases from3.4 to 4.9mm in internal diameter, an ini-
tial hypothetical medial thickness of 131 mm will decreaseThe Journal of Thoracic and Carwith>31% to 90 mm if the aortic wall mass remains un-
changed. Standardization of the medial area measurements
by dividing them to the corresponding internal perimeter
of the vessel as proposed by Tang and colleagues12 showed
no significant difference between elastase-treated and con-
trol aortas (Figure 2,C). This result indicates that the medial
mass had not changed upon elastase application. Similarly,
standardization of the total wall area (mediaþ adventitia)
measurements by dividing them to the internal perimeter
of the vessel showed a significant increase in elastase-
treated aortas compared with control aortas (Figure 2, D)
that must be accounted for by an important increase in the
adventitial area. These results indicate that the wall of the
treated aortas increased in mass, predominantly in the
adventitia, without significant medial thinning.
Quantification of Gelatinases
Pro MMP-2 levels demonstrated no change in elastase-
treated aortas compared with controls at any time point.
In contrast, active MMP-2 levels were not different from
controls at 10 days but had increased significantly 30 daysdiovascular Surgery c Volume 145, Number 6 1629
FIGURE 2. A, Ascending aortic diameters measured by transthoracic ultrasounds preoperatively (elastase n ¼ 15, control n ¼ 6) and at 10-day (elastase
n ¼ 15, control n ¼ 6) and 30-day (elastase n ¼ 10, control n ¼ 3) follow-up. The graph shows each data point and median values (horizontal line). B,
Thickness of the medial layer measured by computer-assisted videomicroscopy. The graph shows median values of each experimental group (elastase
n ¼ 10, control n ¼ 3). C, Standardization of the area of the medial layer by dividing it to the corresponding internal perimeter of the vessel. The graph
shows median values of each experimental group (elastase n ¼ 10, control n ¼ 3). D, Standardization of the total area of vessel wall by dividing it to
the corresponding internal perimeter of the vessel. The graph showsmedian values of each experimental group (elastase n¼ 10, control n¼ 3). E, Activation
of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in the aortic wall of control (n¼ 3) and elastase-treated (n¼ 4) rats at 30-
day follow-up. Representative zymogram is shown with a graph of quantitative analysis of active MMP-2 levels. Gelatin zymography detects 2 major bands
corresponding to the size of proform and active form of MMP-2. *P<.05 versus control group.
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levels demonstrated no change in elastase-treated aortas
compared with controls, at any studied time point.
Histology
Immediately after elastase treatment, the external part
of the media exhibited extensive injury, with destruction
of elastic lamellae on orcein staining (Figure 3, A), and
disappearance of VSMCs as shown by anti a-SMA immu-
nostaining (Figure 3, B). The few remnant VSMCs in the
inner aspect of the media had lost a-SMA expression.TABLE 1. Aortic diameters and aortic wall thicknesses measured by echo
Measure
Preoperative (day 0)
Control
(n ¼ 6)
Elastase
(n ¼ 15)
Control
(n ¼ 3)
Echography measures
Diameter (mm) 3.5 (3.1-3.7) 3.4 (3.2-3.6) 3.4 (3.3-3.5)
Microscopy measures
Media thickness (mm) 135 (85-255)
Media surface/
perimeter (mm)
156.3 (136.7-167.2
Total wall surface/
perimeter (mm)
192.1 (172.1-217.2
Data are presented as median (range). *P<.05 with respect to control value. **P ¼ .004 fo
between preoperative and day 10 measures.
1630 The Journal of Thoracic and Cardiovascular SurAt day 10, there were fragmented and disarrayed elastic
fibers in the media layer and the adventitia was intensely in-
filtrated with cells (Figure 3, C). Expression of a-SMA re-
mained faint in the media but had increased, compared with
day 0. Moreover, an intense a-SMA immunostaining was
observed in the adventitia (Figure 3, D). Sections from con-
trol animals showed normal aortic histology (Figure 3,
E and F).
At day 30, matrix deposition in the external part of the
media and in the adventitia restored the thickness of the aor-
tic wall (Figure 4). The limit between the severely injuredgraphy and microscopy, respectively
Day 10 Day 30
Elastase
(n ¼ 5)
Control
(n ¼ 3)
Elastase
(n ¼ 10)
4.7*** (3.9-5.3) 3.5 (3.4-3.5) 4.9** (4.4-6.2)
107* (25-264) 131 (96-194) 97* (26-219)
) 125.4 (97.5-14.3) 137.8 (121.4-156.8) 130.0 (107.3-183.1)
) 319.9* (302.1-339.2) 155.7 (144.4-179.9) 308.9* (228.8-370.2)
r the difference between day 10 and day 30 measures. ***P<.001 for the difference
gery c June 2013
FIGURE 3. Histologic sections of treated (A-D) and control (E, F) ascending aortae stained with orcein for elastic fibers (A, C, and E) and a-actin (B, D,
and F). Immediately after elastase treatment, there was extensive destruction of elastic lamellae and no expression of a-smooth muscle actin (A, B). At 10-
day follow-up, therewere fragmented and disarrayed elastic fibers in the media and adventitia and faint expression of a-smoothmuscle actin in the media but
an intense expression in the adventitia (C, D). Control aortae at 10-day follow-up show normal architecture of elastic lamellae and a-smooth muscle actin
expression (E, F).
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could not be distinguished. Orcein staining (Figure 4, B)
showed persistent, marked elastic fiber fragmentation and
disarray, resembling elastin injury in human ATAA.13 Sirius
red staining showed less collaged fibers in the media but im-
portant collagen accumulation in the adventitia of elastase-
treated aortas compared with controls (Figure 4, C and D).
Similarly, a-SMA expression remained scarce in the media
but was strong in the adventitia of treated aortas compared
with controls (Figure 4, E and F).
DISCUSSION
Our study demonstrates that elastase application onto the
adventitia of the ascending aorta is feasible in rats through
a sternotomy approach and generates ATAAs that expand
in diameter as shown by transthoracic ultrasoundThe Journal of Thoracic and Carmeasurement in vivo. We also demonstrate that although
the media layer in experimental ATAA is thinned, there is
no reduction of the medial area and that the cross-
sectional total area is increased, in comparison to nondi-
lated, control ascending aorta. The VSMC decrease at the
initial phase of ATAA formation is compensated for by
the accumulation of a-SMA positive cells in a disorganized
extracellular matrix, a scheme specific to aneurysms of the
ascending aorta, in sharp contrast to aneurysms in other lo-
cations of the aorta.1 Lastly, we show that activated MMP-2
contents are increased in experimental ATAA. Accordingly,
adventitial application of elastase in rats is shown to result
in ATAAs that share tissue and cellular organization com-
mon to that of ATAAs in human beings.
Previous studies have reported on the formation of exper-
imental aneurysms at the level of the thoracic aorta. Indiovascular Surgery c Volume 145, Number 6 1631
FIGURE 4. A, C, and E, Sections of control aortae at 30-day follow-up and (B, D, and F) treated aortae at 30-day follow-up. Elastase treatment produced
marked elastic fiber fragmentation (orcein staining [A, B]), decreased collagen in the media but increased collagen production in the adventitia (Sirius red
staining [C, D]). The loss of a-smooth muscle actin expression persisted in the media of treated aortas and was accompanied by its expression in the ad-
ventitia (E, F).
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idase, aneurysms were found involving both the ascending
aorta and the arch, but also in other segments of the aorta.14
Expanding this founding observation, a recent model of
both thoracic and abdominal aneurysms has been described,
by infusing b-aminopropionitrile, a lysyl oxidase inhibitor,
to mice with hypertension induced by angiotensin II or
deoxycorticosterone acetate-salt.15 Ikonomidis and col-
leagues16 induced aneurysm formation in the distal de-
scending thoracic aorta of mice by periadventitial
application of calcium chloride, obtaining in this regionally
distinct aortic segment a model sharing similarities with
thoracoabdominal aneurysms in human beings, but differ-
ent from degenerative ATAAs.16 None of these models
were intended to induce reproducibly aneurysm formation
limited to the ascending aorta, the predominant localization
of thoracic aneurysms in human beings.
Other studies have described thoracic aneurysms in
mice associated with monogenic defects to unravel the1632 The Journal of Thoracic and Cardiovascular Surcontribution of specific genes in syndromes involving the
thoracic aorta in human beings, includingMarfan syndrome
and Loeys-Dietz syndrome.17 Other groups have obtained
aneurysms of the ascending aorta and the aortic arch by
overexpressing S100A12, a ligand to receptors for ad-
vanced glycation end products, targeted to VSMCs.18 These
approaches are based on pathophysiologic assumptions at
the molecular level, distinct from the most common form
of ATAAs in human beings, referred to as degenerative.
Here, we provide evidence that ATAAs can be generated in-
dependently of any genetic background, as in degenerative
ATAAs in human beings.
Proteases have been shown to be determinant in aortic
aneurysm formation.7 Previous reports have shown evi-
dences of increased protease expression in ATAAs.10,19,20
Intraluminal infusion of elastase in rat abdominal aorta
produces experimental aneurysms by medial elastolysis
and secondary inflammatory response.21 This aneurysm
model was used in numerous studies offering severalgery c June 2013
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development and permitted testing several new treatment
approaches.22 However the anatomic and physiologic char-
acteristics of the ascending aorta preclude intraluminal in-
fusion. White and colleagues23 obtained infrarenal
abdominal aneurysms in rabbits by elastase application
onto the adventitia. Aortic diameters continued to increase
up to 2 months of follow-up. Loss of elastin in the adventitia
and the outer part of the media was observed.
Applying elastase on rat ascending aortic adventitia pro-
duced complete destruction of elastic lamellae and elastin
fibers in the adventitia and external part of the media. There
was significant thinning of the medial layer, but standardi-
zation of the medial area by dividing it to the internal perim-
eter of the vessel showed no difference with respect to
controls, despite thinning of the media secondary to vascu-
lar dilation. Also there was a significant increase in total
wall area in treated aortas compared with controls, due to
an important increase in the adventitial area. Similar obser-
vations have been reported from human ATAAs.12
The histologic sections showed that most of the repara-
tive process took place in the outer part of the media and
in the adventitia. At 30-day follow-up we observed that
these layers were intensely repopulated with a-SMA–ex-
pressing cells that were probably responsible for the impor-
tant collagen production shown by the Sirius red staining at
the level of the outer media and adventitia. Although the
thickness was restored by matrix deposition, the normal ar-
chitecture of the vascular wall with regularly disposed elas-
tic lamellae was not reestablished. Thus, histologic
modifications induced by this approach appeared similar
to our previous observations in patients operated on for as-
cending aortic aneurysms with tricuspid aortic valves. In-
deed, at the level of maximal dilation we observed an
important density of VSMCs but the typical lamellar orga-
nization of those cells was altered.13 Similar observations
have been reported by other groups.12
The increased level of active MMP-2 observed at 30 days
after elastase treatment might be responsible for the contin-
uous increase in aortic diameters observed during the
follow-up. Indeed MMP-2 has been associated with dedif-
ferentiated smooth muscle cells that switched from a con-
tractile to a synthetic phenotype, playing a role in
aneurysmal expansion.20
Despite reproducing several observations from human
pathology, this model has several limitations. Aneurysms
obtained after elastase application onto the adventitia
were limited to the tubular portion of the ascending aorta
without involvement of the aortic root or the aortic valve,
perhaps due to insufficient exposure of the aortic root to
elastase. The ascending aorta has to be considered as 1 func-
tional unit. Alteration of 1 of its components will have im-
portant consequences on the function of the aortic root as
a whole. Thus, optimal aortic valve function (opening andThe Journal of Thoracic and Carclosing) closely relies on aortic root morphology (eg, si-
nuses of Valsalva and sinotubular junction) and its elastic
components.7 Conversely, primary or secondary aortic
valve dysfunction resulting in significant stenosis or regur-
gitation will obviously lead to disturbed aortic blood flow
patterns eventually contributing to the development or en-
hancement of aortic wall disease.24 However, ATAAs in hu-
man beings can develop without associated aortic valve
incompetence.
CONCLUSIONS
We provide a description of the first model of degenera-
tive ATAA in rodents, limited to the ascending aorta as the
most common location of thoracic aortic aneurysms in hu-
man beings. Our finding that ATAAs obtained in rats after
elastase application exhibit structural features common to
human ATAAs suggests that the ascending aorta behaves
in a particular and specific way to elastase injury. This
newmodel may help provide insights into the pathophysiol-
ogy of this common and life-threatening condition, allow-
ing for the design of new therapeutic approaches.
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